Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neocarzinostatin apoprotein is a 113-amino acid protein produced by Streptomyces carzinostaticus that functions as a specific carrier for the highly reactive neocarzinostatin chromophore (UniProt P02840). This apoprotein belongs to the enediyne-binding protein family and is essential for protecting the labile chromophore from nucleophilic attack and spontaneous degradation in aqueous environments (PubMed: 1551346). The resulting holo-protein complex, known as Neocarzinostatin or Zinostatin, is a potent antitumor antibiotic that targets DNA (DrugBank DB06159). The apoprotein facilitates the delivery of the chromophore to the minor groove of DNA, where the chromophore undergoes an activation process to generate a diradical species that causes double-strand breaks (PubMed: 2103035). While the apoprotein itself lacks cytotoxic activity, its high affinity for the chromophore is critical for the drug's stability and pharmacological profile (PubMed: 8401200). Clinical use of the complex has been explored for various malignancies, but challenges include its potential for immunogenicity as a foreign bacterial protein (PubMed: 3884400).
The apoprotein acts as a protective carrier for the neocarzinostatin chromophore, stabilizing its enediyne core and delivering it to the DNA minor groove where the chromophore induces double-strand breaks.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neocarzinostatin apoprotein (Apo-NCS).